Fig. 4
From: The outcome of thrombotic microangiopathy in kidney transplant recipients

Kaplan–Meier allograft survival estimates according to the use of eculizumab
From: The outcome of thrombotic microangiopathy in kidney transplant recipients
Kaplan–Meier allograft survival estimates according to the use of eculizumab